Table 1.
A rapid review of cost-effectiveness analyses of G-CSF prophylaxis among lymphoma patients undergoing CHOP-based chemotherapy.
Fig 1.
Structure of Markov state transition model.
Fig 2.
Markov trace of the cohort simulation for the first two cycles of chemotherapy.
Table 2.
Model inputs.
Table 3.
Results of the costs and effectiveness of the prophylaxis strategies (cost per FN episode prevented).
Fig 3.
Cost-effective acceptability curve (cost per FN episode prevented).
Table 4.
Results of the costs and effectiveness of the prophylaxis strategies (cost per QALY gained).